Type-1 CD4+ T (Th1) cells in particular appear crucial for optimal induction, recruitment, and long-term maintenance of therapeutic anti-tumor CD8+ T cells and anti-tumor immunity (12–15). This evidence concerns the gene CD8A and neoplasm.